Literature DB >> 2869639

Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.

H Hall, M Sällemark, E Jerning.   

Abstract

A number of potential neuroleptic drugs of the substituted benzamide type have been compared with some reference neuroleptic drugs regarding their affinities for rat brain receptors using in vitro receptor binding techniques. The effects on dopamine-stimulated adenylate cyclase were also investigated. All 6-methoxysalicylamides were very potent inhibitors of the dopamine-D2 receptor and possessed much less affinity for other receptors as well as for the dopamine-stimulated adenylate cyclase. In contrast, the classical neuroleptic drugs were not selective dopamine-D2 receptor blockers. Several of these neuroleptics were thus potent inhibitors of alpha 1-receptors, 5-HT2 receptors, muscarinic receptors and histamine-H1 receptors. Sulpiride was the most selective dopamine-D2 receptor blocker of the reference compounds with a selectivity ratio of 65. The 6-methoxysalicylamides had selectivity ratios ranging from 18 to 167.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2869639     DOI: 10.1111/j.1600-0773.1986.tb00071.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  24 in total

1.  Pharmacokinetics and effects on prolactin of remoxipride in patients with tardive dyskinesia.

Authors:  E Widerlöv; U Andersson; C von Bahr; M I Nilsson
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 2.  A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride.

Authors:  Jennifer L Martelle; Michael A Nader
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

3.  Inhibitory effects on the discriminative stimulus properties of D-amphetamine by classical and newer antipsychotics do not correlate with antipsychotic activity. Relation to effects on the reward system?

Authors:  J Arnt
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

4.  Effect of urinary pH on the plasma and urinary kinetics of remoxipride in man.

Authors:  E Widerlöv; B Termander; M I Nilsson
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Human dopamine receptor subtypes--in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride.

Authors:  H Hall; L Farde; G Sedvall
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

6.  Adrenergic, serotoninergic, histaminergic, and imipramine binding sites in post-mortal human cerebral microvessel preparations.

Authors:  C O'Neill; C J Fowler; J O Marcusson; B Winblad
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

7.  The role of dopaminergic transmission through D1-like and D2-like receptors in amphetamine-induced rat ultrasonic vocalizations.

Authors:  Jennifer M Wright; May R S Dobosiewicz; Paul B S Clarke
Journal:  Psychopharmacology (Berl)       Date:  2012-09-28       Impact factor: 4.530

8.  Dopamine invigorates reward seeking by promoting cue-evoked excitation in the nucleus accumbens.

Authors:  Johann du Hoffmann; Saleem M Nicola
Journal:  J Neurosci       Date:  2014-10-22       Impact factor: 6.167

9.  Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL/6 mice.

Authors:  Timothy J Donahue; Todd M Hillhouse; Kevin A Webster; Richard Young; Eliseu O De Oliveira; Joseph H Porter
Journal:  Psychopharmacology (Berl)       Date:  2017-09-18       Impact factor: 4.530

10.  Peripheral and central adrenoceptor modulation of the behavioural effects of clozapine in the paw test.

Authors:  E P Prinssen; B A Ellenbroek; A R Cools
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.